跳至主要内容
临床试验/CTRI/2022/02/040063
CTRI/2022/02/040063招募中不适用

MMC Rheumatic Heart Disease Registry

Madras Medical College1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年8月2日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
Mortality

研究概览

简要总结

Literature of the profile, pattern and intermediate term outcome of patients with Rheumatic Heart Disease from South India in the recent era, is scarce.

This registry seeks to collect information regarding the same.

All patients seeking care in our institution with rheumatic heart disease will be enrolled and followed up for three years.

研究设计

研究类型
Observational

入排标准

年龄范围
5.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • 1.All consecutive patients diagnosed to have definite RHD using standard clinical and echocardiographic criteria, seen at outpatient facilities, emergency departments, or inpatient facilities of the participating hospitals irrespective of their age and other comorbidities during the study period are eligible for inclusion in the study.
  • 2.Inpatients will be eligible if RHD is the reason for their admission to hospital.
  • This will include conditions directly attributable to RHD, such as, heart failure, cardiac arrhythmia, and stroke.

排除标准

  • 1.Patients with primary diagnosis of valvular disease other than RHD (eg, degenerative disease) 2.Patients with borderline criteria for RHD 3.No informed consent/assent.
  • 4.Patients without evidence of echocardiography ascertained valvular disease were excluded.

结局指标

主要结局

Mortality

时间窗: One year Three year

Cardiac Hospitalisation

时间窗: One year Three year

次要结局

  • Surgery of Intervention(Other Complication)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验